Heterogeneity in the treatment of moderately severe scalp psoriasis in Scotland – results of a survey of Scottish health professionals

Author： Smith Douglas R.W.   Bottomley Julia M.   Auland Merran   Jackson Peter   Sharp Judith  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.27, Iss.1, 2011-01, pp. : 239-249

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The two-compound formulation of calcipotriol and betamethasone dipropionate for treatment of moderately severe body and scalp psoriasis – an introduction

By Freeman Keith  

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 197-203

Informa Healthcare

Access to resources Recommend Favorite

The effectiveness of two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of moderately severe scalp psoriasis: A systematic review of direct and indirect evidence

By Bottomley Julia M.   Taylor Rod S.   Ryttov Jacob  

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 251-268

Informa Healthcare

Access to resources Recommend Favorite

Cost effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of scalp psoriasis in Scotland

By Affleck Andrew G.   Bottomley Julia M.   Auland Merran   Jackson Peter   Ryttov Jacob  

Current Medical Research and Opinion, Vol. 27, Iss. 1, 2011-01 ,pp. : 269-284

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in Scotland

By Bottomley Julia M.   Auland Merran E.   Morais Jeremy   Boyd Gordon   Douglas W. Stewart  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1887-1901

Informa Healthcare

Access to resources Recommend Favorite

Adalimumab for the treatment of moderate to severe psoriasis: subanalysis of effects on scalp and nails in the BELIEVE study

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 2, 2015-02 ,pp. : 353-360

John Wiley & Sons Inc

Access to resources Recommend Favorite